'On consolidated basis

Quarter ended December 2024 compared with Quarter ended December 2023.

Net sales (including other operating income) of Divis Laboratories has increased 25.01% to Rs 2319 crore.  Operating profit margin has jumped from 26.36% to 32.04%, leading to 51.94% rise in operating profit to Rs 743.00 crore.  Raw material cost as a % of total sales (net of stock adjustments) increased from 41.35% to 42.22%.   Employee cost decreased from 13.96% to 12.28%.   Other expenses fell from 19.22% to 14.76%.   

Other income fell 13.68% to Rs 82 crore.  PBIDT rose 41.27% to Rs 825 crore.  Provision for interest remained nil.  

PBDT rose 41.27% to Rs 825 crore.  Provision for depreciation rose 4.21% to Rs 99 crore.  

Profit before tax grew 48.47% to Rs 726.00 crore.  Share of profit/loss were nil in both the periods.  Prov...

• 

  (01-Mar-2025)

  Foseco India

  OP up 17%
• 

  (28-Feb-2025)

  Schaeffler India

  Maintains double digit revenue growth and stable OPM
• 

  (28-Feb-2025)

  Sanofi India

  OP up 18.78%
• 

  (28-Feb-2025)

  KSB

  Net up 33% largely on higher sales, higher OI and lower taxation